Antisense oligonucleotide (ASO) in SMA: from bench-to-bedside

September 24, 2020

12:00 — 13:30 pm CEST

THURSDAY

Show in my time zone

What will be discussed:

  • The science behind nusinersen.▼
  • Exploring the clinical applications of nusinersen.

Meet the speaker:

Wildon Farwell, MD, MPH


Global Medical Head of Neuromuscular Diseases at Biogen, Cambridge, MA, USA.

Loading…

Please fill out the following information for your registration

*
*
*
*
 
 
*

Meet the speaker:

Wildon Farwell, MD, MPH


Global Medical Head of Neuromuscular Diseases at Biogen, Cambridge, MA, USA.